Searchable News & Info From Reliable Online Sources.
Latest Real News From 140 News Sites Updated Every 15 Minutes.
- Is “fibermaxxing” good for your health?
Health and fitness influencers are pushing people to consume more fiber. Keri Glassman, Nutritious Life founder and CEO, joins with her take. [TheTopNews] Read More.1 week ago - FMCSA Removes More Than a Dozen ELDs from Registered List
The Federal Motor Carrier Safety Administration (FMCSA) has removed more than a dozen electronic logging devices (ELDs) from its registered ELD list after determining the devices failed to meet federal compliance requirements. The latest removals are part of FMCSA’s ongoing effort to improve oversight of electronic logging devices and reduce the use of systems that do not properly meet Hours of Service (HOS) regulations. Motor carriers using the revoked ELDs now have up to 60 days to replace them with compliant devices listed on FMCSA’s approved ELD registry. FMCSA Removes Multiple ELD Providers On May 20, FMCSA removed 12 ELDs from its registered device list. The agency stated that the devices failed to meet minimum federal ELD requirements. The revoked devices include: 888 ELD from MAUMAU LLC Dragon ELD Action ELD Mondo ELD HOS First ELD First ELD V2.0 MTL ELD USPower ELD Sam Freight ELD DSGELOGS Cobra ELD GT USA ELOGS Earlier in May, FMCSA also removed Safe ELD and MYLOGS ELD from the approved list for similar compliance failures. All affected devices now appear on FMCSA’s official Revoked Devices list. What Motor Carriers Need to Do Motor carriers and drivers currently using these ELDs must stop using them before the 60-day deadline expires. Until carriers install a compliant ELD, drivers may switch to paper logs or approved logging software to continue recording Hours of Service data. After the deadline, drivers using revoked ELDs could face serious violations during roadside inspections. FMCSA warned that drivers who continue using noncompliant devices after the deadline may be cited for “No record of duty status” violations under federal regulations. In addition, drivers could also be placed out of service under Commercial Vehicle Safety Alliance (CVSA) enforcement criteria. Because of this, FMCSA strongly recommends carriers begin replacing revoked devices immediately rather than waiting until the deadline approaches. FMCSA Continues Push for Stronger ELD Oversight The agency has increased its focus on ELD oversight in recent months. FMCSA officials say outdated approval processes allowed some noncompliant devices to remain on the market for too long. Late last year, FMCSA announced plans to strengthen how electronic logging devices are reviewed and approved. While the agency stopped short of adopting Canada’s full third-party certification model, it did introduce additional safeguards aimed at improving device verification and compliance monitoring. The agency hopes the stronger review process will help prevent fraudulent or unreliable ELD… [TheTopNews] Read More.1 week ago - ‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease...
As GLP-1 weight-loss medications gain traction, the peptide market is experiencing a surge in interest.A variety of peptides — commonly marketed for weight loss, muscle building, injury recovery and other uses — have emerged as largely unregulated drugs sold through both licensed compounding pharmacies and unverified vendors.The U.S. Food and Drug Administration is set to evaluate whether to loosen regulations on several peptides during a meeting this summer.THINKING ABOUT PEPTIDES? DOCTORS REVEAL KEY DOS AND DON’TS AS ‘WILD WEST’ MARKET GROWSPeptides are short chains of amino acids — the building blocks of proteins — that play key roles in biological functions, according to the National Institutes of Health. Peptide drugs are lab-made versions of natural molecules in the body that are designed to mimic or influence biological signals to treat disease, experts say.Though the peptide market has been described as the "Wild West," demand remains strong, potentially challenging pharmaceutical giants that dominate the GLP-1 market.Dr. Alex Tatem, an Indiana-based board-certified urologist with expertise in men’s health and peptides, discussed how "life-changing" GLP-1s kicked off the rise of peptides."They are incredibly effective at what they do when it comes to changing body composition, benefiting metabolic health, cardiovascular health [and] neurologic health," he said. "These are truly miracle compounds, and as a result we've seen an explosion of interest – not just on the pharmaceutical side or the doctor’s side, but from the general public."According to Tatem, the challenge is that nearly all commercial GLP-1 products are administered in a single-dose weekly pen, which works for the "overwhelmingly majority" of patients, but not for everyone.OZEMPIC ‘MICRODOSING’ IS THE NEW WEIGHT-LOSS TREND: SHOULD YOU TRY IT?"There are patients I can prescribe tirzepatide to and they can do OK with a once-a-week [dose], but they end up developing nausea with that initial injection – and then by the end of the week, they're hungry again."Because some patients respond better to smaller, more frequent doses — an option not offered by commercial drugs — compounding, or the customization of medications, has grown in popularity, Tatem said."We've had compounding pharmacies that have now developed compounded versions of semaglutide and tirzepatide that allow that sort of dosing flexibility," he said."The reason compounders had to do this was because there was so much demand for GLP-1s that there was actually a national shortage."Current legislation allows compounders to step in during widespread national shortages, according to Tatem, prompting the… [TheTopNews] Read More.1 week ago - The Typo Vibe Shift
Toward the beginning of the 2002 film Secretary, a domineering lawyer (played by James Spader) barges into the office of his assistant (Maggie Gyllenhaal) with evidence of a work infraction: a memo she has written that has “three typing errors.” Spader’s character spits out a reprimand. “Do you know what this makes me look like to the people who receive these letters?”Setting aside that his screed turns out to be foreplay, Spader’s character was channeling a widespread cultural revulsion: Typos were the ultimate shorthand for careless work. A spelling mistake was proof that the writer hadn’t bothered putting much effort into a piece of correspondence, that their instructions or advice shouldn’t be taken seriously—and perhaps that the recipient shouldn’t invest time in reading their note at all.More than two decades later, as AI-generated writing has flooded workplaces, social media, and dating apps, old hallmarks of sloppiness—typos chief among them—are getting a new gloss.[Read: The problem with using AI in your personal life]Some job applicants are intentionally adding typos to their cover letters to prove that they, and not an AI program, wrote them. Celebrities and CEOs are sending out error-ridden emails and Instagram Stories, and instead of getting a scolding, they are praised for sounding authentic. On some dating apps, where people are, somewhat absurdly, prompted to compose their profiles with AI, typos are apparently no longer an automatic repellant. Nicole Ellison, a University of Michigan professor whose 2006 study showed that dating profiles with spelling mistakes turn people off, now thinks people are warming to the Tinder typo. “A typo maybe signals that you actually do care,” Ellison told Time recently, “because you took the time to write it yourself.” A 2024 study even found that people view customer-service chatbots more warmly when they make and correct errors: A spelling mistake, it seems, is a kind of anthropomorphizing event.A peculiar reconfiguration of what people consider careless writing is taking place. Although typos and other mistakes don’t suddenly mean that a piece of writing is good or praiseworthy, to some people, they are at least signs that it is worth reading. On a base level, many of us are willing to invest time in reading a long email if we sense that someone actually wrote it, line by line.In England’s early-modern period, starting around the 1500s, readers understood typos to be inevitable technological blunders. Books were produced collaboratively; writers sent… [TheTopNews] Read More.1 week ago - New obesity treatment may help preserve muscle during weight lossDuring a recent episode of her podcast, Gwyneth Paltrow spoke with neuroscientist Dr. Andrew Huberman about retatrutide, a new advancement in GLP-1 (glucagon-like peptide-1) therapies.In recent years, GLP-1 receptor agonists have become a major focus in discussions around biohacking, longevity and wellness – but they’re not without a multitude of side effects.Huberman noted that while first-generation weight-loss drugs curbed users' appetites, they frequently plunged them into massive, rapid caloric deficits.'NEXT OZEMPIC' AIMS TO DELIVER 30% WEIGHT LOSS WITH FEWER SIDE EFFECTSWithout aggressive resistance training, a high percentage of that lost weight came directly from lean muscle. "People would lose a ton of weight, but they would also lose muscle mass," Huberman told Paltrow.That is where retatrutide comes in, he said. Unlike older single- or dual-action medications, retatrutide is a triple agonist.That means it activates the body's receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon – three hormones involved in regulating blood sugar, appetite and metabolism.WEIGHT-LOSS EXPERTS PREDICT 5 MAJOR TREATMENT CHANGES LIKELY TO EMERGE IN 2026"Retatrutide is a more mild agonist of GLP-1," said Huberman. "It also increases glucagon and ... GIP. So, it hits three different pathways, each a bit more subtly."In clinical trials, retatrutide is administered as a once-weekly subcutaneous injection.Because of its balanced, multi-receptor approach, Huberman said the drug has a "lower side effect profile" while still allowing people to lose up to a third of their body weight "across a year or so."NEW OZEMPIC-ALTERNATIVE DIABETES PILL BURNS FAT WITHOUT MUSCLE LOSS, STUDY SUGGESTSMost importantly for fitness and longevity advocates, the doctor pointed out that retatrutide seems to have "some muscle sparing effect."Because the drug is still moving through official pipelines, a massive gray market of compounding pharmacies and online peptide suppliers has cropped up to meet the growing demand.Huberman issued a strict warning regarding these unregulated online sources, noting that these options "can say 99% purity, but that 1% means there could be some LPS," referring to lipopolysaccharides, a type of bacterial toxin.CLICK HERE FOR MORE HEALTH STORIES"LPS will cause inflammation," he cautioned. "One injection isn't gonna do it, but multiple injections over time, I could see where that could become problematic."CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERPaltrow echoed the safety concerns, comparing the current "wild-west" peptide craze to the landscape of supplements in the 90s, "where there's really no third-party testing and it's kind of word of mouth."Both agreed that… [TheTopNews] Read More.1 week ago
« Previous
1
…
99
100
101
102
103
…
111
Next »
Health and fitness influencers are pushing people to consume more fiber. Keri Glassman, Nutritious Life founder and CEO, joins with her take. [TheTopNews] Read More.
1 week ago
The Federal Motor Carrier Safety Administration (FMCSA) has removed more than a dozen electronic logging devices (ELDs) from its registered ELD list after determining the devices failed to meet federal compliance requirements. The latest removals are part of FMCSA’s ongoing effort to improve oversight of electronic logging devices and reduce the use of systems that do not properly meet Hours of Service (HOS) regulations. Motor carriers using the revoked ELDs now have up to 60 days to replace them with compliant devices listed on FMCSA’s approved ELD registry. FMCSA Removes Multiple ELD Providers On May 20, FMCSA removed 12 ELDs from its registered device list. The agency stated that the devices failed to meet minimum federal ELD requirements. The revoked devices include: 888 ELD from MAUMAU LLC Dragon ELD Action ELD Mondo ELD HOS First ELD First ELD V2.0 MTL ELD USPower ELD Sam Freight ELD DSGELOGS Cobra ELD GT USA ELOGS Earlier in May, FMCSA also removed Safe ELD and MYLOGS ELD from the approved list for similar compliance failures. All affected devices now appear on FMCSA’s official Revoked Devices list. What Motor Carriers Need to Do Motor carriers and drivers currently using these ELDs must stop using them before the 60-day deadline expires. Until carriers install a compliant ELD, drivers may switch to paper logs or approved logging software to continue recording Hours of Service data. After the deadline, drivers using revoked ELDs could face serious violations during roadside inspections. FMCSA warned that drivers who continue using noncompliant devices after the deadline may be cited for “No record of duty status” violations under federal regulations. In addition, drivers could also be placed out of service under Commercial Vehicle Safety Alliance (CVSA) enforcement criteria. Because of this, FMCSA strongly recommends carriers begin replacing revoked devices immediately rather than waiting until the deadline approaches. FMCSA Continues Push for Stronger ELD Oversight The agency has increased its focus on ELD oversight in recent months. FMCSA officials say outdated approval processes allowed some noncompliant devices to remain on the market for too long. Late last year, FMCSA announced plans to strengthen how electronic logging devices are reviewed and approved. While the agency stopped short of adopting Canada’s full third-party certification model, it did introduce additional safeguards aimed at improving device verification and compliance monitoring. The agency hopes the stronger review process will help prevent fraudulent or unreliable ELD… [TheTopNews] Read More.
1 week ago
As GLP-1 weight-loss medications gain traction, the peptide market is experiencing a surge in interest.A variety of peptides — commonly marketed for weight loss, muscle building, injury recovery and other uses — have emerged as largely unregulated drugs sold through both licensed compounding pharmacies and unverified vendors.The U.S. Food and Drug Administration is set to evaluate whether to loosen regulations on several peptides during a meeting this summer.THINKING ABOUT PEPTIDES? DOCTORS REVEAL KEY DOS AND DON’TS AS ‘WILD WEST’ MARKET GROWSPeptides are short chains of amino acids — the building blocks of proteins — that play key roles in biological functions, according to the National Institutes of Health. Peptide drugs are lab-made versions of natural molecules in the body that are designed to mimic or influence biological signals to treat disease, experts say.Though the peptide market has been described as the "Wild West," demand remains strong, potentially challenging pharmaceutical giants that dominate the GLP-1 market.Dr. Alex Tatem, an Indiana-based board-certified urologist with expertise in men’s health and peptides, discussed how "life-changing" GLP-1s kicked off the rise of peptides."They are incredibly effective at what they do when it comes to changing body composition, benefiting metabolic health, cardiovascular health [and] neurologic health," he said. "These are truly miracle compounds, and as a result we've seen an explosion of interest – not just on the pharmaceutical side or the doctor’s side, but from the general public."According to Tatem, the challenge is that nearly all commercial GLP-1 products are administered in a single-dose weekly pen, which works for the "overwhelmingly majority" of patients, but not for everyone.OZEMPIC ‘MICRODOSING’ IS THE NEW WEIGHT-LOSS TREND: SHOULD YOU TRY IT?"There are patients I can prescribe tirzepatide to and they can do OK with a once-a-week [dose], but they end up developing nausea with that initial injection – and then by the end of the week, they're hungry again."Because some patients respond better to smaller, more frequent doses — an option not offered by commercial drugs — compounding, or the customization of medications, has grown in popularity, Tatem said."We've had compounding pharmacies that have now developed compounded versions of semaglutide and tirzepatide that allow that sort of dosing flexibility," he said."The reason compounders had to do this was because there was so much demand for GLP-1s that there was actually a national shortage."Current legislation allows compounders to step in during widespread national shortages, according to Tatem, prompting the… [TheTopNews] Read More.
1 week ago
Toward the beginning of the 2002 film Secretary, a domineering lawyer (played by James Spader) barges into the office of his assistant (Maggie Gyllenhaal) with evidence of a work infraction: a memo she has written that has “three typing errors.” Spader’s character spits out a reprimand. “Do you know what this makes me look like to the people who receive these letters?”Setting aside that his screed turns out to be foreplay, Spader’s character was channeling a widespread cultural revulsion: Typos were the ultimate shorthand for careless work. A spelling mistake was proof that the writer hadn’t bothered putting much effort into a piece of correspondence, that their instructions or advice shouldn’t be taken seriously—and perhaps that the recipient shouldn’t invest time in reading their note at all.More than two decades later, as AI-generated writing has flooded workplaces, social media, and dating apps, old hallmarks of sloppiness—typos chief among them—are getting a new gloss.[Read: The problem with using AI in your personal life]Some job applicants are intentionally adding typos to their cover letters to prove that they, and not an AI program, wrote them. Celebrities and CEOs are sending out error-ridden emails and Instagram Stories, and instead of getting a scolding, they are praised for sounding authentic. On some dating apps, where people are, somewhat absurdly, prompted to compose their profiles with AI, typos are apparently no longer an automatic repellant. Nicole Ellison, a University of Michigan professor whose 2006 study showed that dating profiles with spelling mistakes turn people off, now thinks people are warming to the Tinder typo. “A typo maybe signals that you actually do care,” Ellison told Time recently, “because you took the time to write it yourself.” A 2024 study even found that people view customer-service chatbots more warmly when they make and correct errors: A spelling mistake, it seems, is a kind of anthropomorphizing event.A peculiar reconfiguration of what people consider careless writing is taking place. Although typos and other mistakes don’t suddenly mean that a piece of writing is good or praiseworthy, to some people, they are at least signs that it is worth reading. On a base level, many of us are willing to invest time in reading a long email if we sense that someone actually wrote it, line by line.In England’s early-modern period, starting around the 1500s, readers understood typos to be inevitable technological blunders. Books were produced collaboratively; writers sent… [TheTopNews] Read More.
1 week ago
During a recent episode of her podcast, Gwyneth Paltrow spoke with neuroscientist Dr. Andrew Huberman about retatrutide, a new advancement in GLP-1 (glucagon-like peptide-1) therapies.In recent years, GLP-1 receptor agonists have become a major focus in discussions around biohacking, longevity and wellness – but they’re not without a multitude of side effects.Huberman noted that while first-generation weight-loss drugs curbed users' appetites, they frequently plunged them into massive, rapid caloric deficits.'NEXT OZEMPIC' AIMS TO DELIVER 30% WEIGHT LOSS WITH FEWER SIDE EFFECTSWithout aggressive resistance training, a high percentage of that lost weight came directly from lean muscle. "People would lose a ton of weight, but they would also lose muscle mass," Huberman told Paltrow.That is where retatrutide comes in, he said. Unlike older single- or dual-action medications, retatrutide is a triple agonist.That means it activates the body's receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon – three hormones involved in regulating blood sugar, appetite and metabolism.WEIGHT-LOSS EXPERTS PREDICT 5 MAJOR TREATMENT CHANGES LIKELY TO EMERGE IN 2026"Retatrutide is a more mild agonist of GLP-1," said Huberman. "It also increases glucagon and ... GIP. So, it hits three different pathways, each a bit more subtly."In clinical trials, retatrutide is administered as a once-weekly subcutaneous injection.Because of its balanced, multi-receptor approach, Huberman said the drug has a "lower side effect profile" while still allowing people to lose up to a third of their body weight "across a year or so."NEW OZEMPIC-ALTERNATIVE DIABETES PILL BURNS FAT WITHOUT MUSCLE LOSS, STUDY SUGGESTSMost importantly for fitness and longevity advocates, the doctor pointed out that retatrutide seems to have "some muscle sparing effect."Because the drug is still moving through official pipelines, a massive gray market of compounding pharmacies and online peptide suppliers has cropped up to meet the growing demand.Huberman issued a strict warning regarding these unregulated online sources, noting that these options "can say 99% purity, but that 1% means there could be some LPS," referring to lipopolysaccharides, a type of bacterial toxin.CLICK HERE FOR MORE HEALTH STORIES"LPS will cause inflammation," he cautioned. "One injection isn't gonna do it, but multiple injections over time, I could see where that could become problematic."CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERPaltrow echoed the safety concerns, comparing the current "wild-west" peptide craze to the landscape of supplements in the 90s, "where there's really no third-party testing and it's kind of word of mouth."Both agreed that… [TheTopNews] Read More.
1 week ago
The Searchable USWebDaily.com and TheTopNews NewsBank Helps You Be Better Informed, Faster! Spread The Word.
